Sun Pharmaceuticals reported INR20.61B in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aspen Pharmacare APN:SJ 336B 333.74B
Bharat Petroleum BPCL:IN -61479400000 89.51B
Cipla CIPLA:IN IR 6864M 3243.3M
Dr.Reddys Laboratories DRRD:IN IR 11890M 10920M
Jiangsu Hengrui Me. 600276:CH CH 882.38M 354.57M
Reliance Infra RELI:IN IR 179550M 17520M
Sh Fosun Pharma 600196:CH CH 1.08B 622.31M
Sun Pharmaceuticals SUNP:IN IR 20608.8M 43381.3M
UPL UPLL:IN IR 8770M 5020M